ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

Hopkins Oncology Center Renamed To Honor Sidney Kimmel

May 10, 2002

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies

March 8, 2013

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013